Title | Cerebral metabolic rate of oxygen (CMRO ) mapping by combining quantitative susceptibility mapping (QSM) and quantitative blood oxygenation level-dependent imaging (qBOLD). |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Cho J, Kee Y, Spincemaille P, Nguyen TD, Zhang J, Gupta A, Zhang S, Wang Y |
Journal | Magn Reson Med |
Volume | 80 |
Issue | 4 |
Pagination | 1595-1604 |
Date Published | 2018 10 |
ISSN | 1522-2594 |
Keywords | Adult, Algorithms, Brain, Brain Mapping, Female, Gray Matter, Humans, Imaging, Three-Dimensional, Magnetic Resonance Imaging, Male, Middle Aged, Oxygen, Young Adult |
Abstract | PURPOSE: To map the cerebral metabolic rate of oxygen (CMRO ) by estimating the oxygen extraction fraction (OEF) from gradient echo imaging (GRE) using phase and magnitude of the GRE data. THEORY AND METHODS: 3D multi-echo gradient echo imaging and perfusion imaging with arterial spin labeling were performed in 11 healthy subjects. CMRO and OEF maps were reconstructed by joint quantitative susceptibility mapping (QSM) to process GRE phases and quantitative blood oxygen level-dependent (qBOLD) modeling to process GRE magnitudes. Comparisons with QSM and qBOLD alone were performed using ROI analysis, paired t-tests, and Bland-Altman plot. RESULTS: The average CMRO value in cortical gray matter across subjects were 140.4 ± 14.9, 134.1 ± 12.5, and 184.6 ± 17.9 μmol/100 g/min, with corresponding OEFs of 30.9 ± 3.4%, 30.0 ± 1.8%, and 40.9 ± 2.4% for methods based on QSM, qBOLD, and QSM+qBOLD, respectively. QSM+qBOLD provided the highest CMRO contrast between gray and white matter, more uniform OEF than QSM, and less noisy OEF than qBOLD. CONCLUSION: Quantitative CMRO mapping that fits the entire complex GRE data is feasible by combining QSM analysis of phase and qBOLD analysis of magnitude. |
DOI | 10.1002/mrm.27135 |
Alternate Journal | Magn Reson Med |
PubMed ID | 29516537 |
PubMed Central ID | PMC6097883 |
Grant List | R21 EB024366 / EB / NIBIB NIH HHS / United States R01 NS090464 / NS / NINDS NIH HHS / United States R01 NS095562 / NS / NINDS NIH HHS / United States S10 OD021782 / OD / NIH HHS / United States R01 CA181566 / CA / NCI NIH HHS / United States |
Related Institute:
MRI Research Institute (MRIRI)